1. OP0115 Efficacy of Belimumab in Systemic Lupus Erythematosus Patients with High Disease Activity in Key Organ Systems: Bliss Sub-Populations. (23rd January 2014) Authors: Schmitt, C.; Roth, D.; Birch, H.; Kleoudis, C.; De Vries, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS. (2nd June 2020) Authors: Furie, R.; Rovin, B. H.; Houssiau, F.; Amoura, Z.; Santiago, M.; Contreras, G.; Malvar, A.; Mok, C. C.; Saxena, A.; Yu, X.; Teng, Y. K. O.; Barnett, C.; Burriss, S.; Green, Y.; Ji, B.; Kleoudis, C.; Roth, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗